Technology

Life Sciences

Farella Braun + Martel has a multidisciplinary team of attorneys who represent life science, medical product and healthcare technology companies, including biotechnology companies, medical device manufacturers, pharmaceutical companies, software companies, investment banks and venture capital firms.

We provide assistance to life sciences companies at every stage of development, from startup and emerging enterprises to late stage companies. At the root of our work is a strong desire to assist innovators to create and protect the next generation of technologies that will save and improve life globally. Our lawyers have the education and experience to dive into and unpack the science at the heart of many of the high-stakes matters our life sciences clients face, utilizing both their own scientific backgrounds and technical experts to ensure that our clients’ stories can be told accurately, clearly, concisely, and persuasively to judges, juries, arbitrators and regulatory agencies.

Farella’s life sciences team is truly cross-functional. We have deep experience in commercial, intellectual property, employment, insurance coverage, securities and white collar criminal litigation as well as product liability and product stewardship. Our litigators have handled a range of patent, licensing, indemnity, insurance recovery and contract disputes involving technologies as varied as eukaryotic cells transformed with recombinant DNA plasmids, erythropoietin (EPO) mimetic peptides, vascular closure devices, phage display and PCR-related technology. The white collar crime and internal corporate investigations team has extensive experience representing life sciences companies and their executives, including in conducting internal investigations and in defending against government actions and investigations relating to allegations of off-label marketing. Our environmental and products lawyers have defended life sciences clients in products liability claims, device defect litigation and in conducting sensitive internal employee health investigations. Our corporate attorneys are experienced in all forms of business transactions, including traditional M&A, licensing deals, joint ventures, and strategic investments—and can readily switch between them as required to meet our client's objective.

Firm Highlights

News

Farella COVID-19 Update: A Message From the Managing Partner

To our clients, alumni and friends, During these unsettling times, Farella Braun + Martel is focused on protecting the health and safety of our firm members, clients, and communities and doing our part to...

Read More
Event

Berkeley Boosts Shorts: Financial Crises and Insurance

In light of the coronavirus crisis and its impact on work and financial markets, Berkeley Law will be hosting short, live daily video interviews with leading voices from law and business. Farella's Tyler Gerking...

Read More
News

Insurers Brace for Coronavirus Hit to ‘Event Driven’ D&O Line

Mary McCutcheon was quote in the Claims Journal article,"Insurers Brace for Coronavirus Hit to ‘Event Driven’ D&O Line." Link to read the full article .

Read More
Publication

Tax Relief in Response to the COVID-19 Outbreak

In order to combat the adverse economic effects in which many individuals and businesses are experiencing as a result of the COVID-19 outbreak, the federal government and the State of California will provide tax...

Read More
Event

7th Annual Partner Compensation One-Day Workshop

Brian Donnelly is presenting the case study session, "Managing Partner Performance" at Fairfax Associates' 7th Annual Partner Compensation One-Day Workshop. Click here for more information.

Read More
Publication

Impacts of Recent PTAB Precedential Opinions Addressing Its Discretion to Reject Petitions for Review of Issued Patents

The Patent Trial and Appeal Board (PTAB) recently designated two more opinions as “precedential” dealing with its discretion to reject petitions for inter partes review (IPR) or similar post-grant reviews. Under 35 U.S.C. § 325(d...

Read More
News

Daily Journal Names Farella Lawyers Among Top IP Lawyers in California

Farella Braun + Martel is proud to announce that partners Jeffrey M. Fisher and James L. Day were named to the 2020 list of “Top Intellectual Property Lawyers” in California by the Daily Journal...

Read More
Event

Advising Businesses and Practicing Law During COVID-19

Rebecca Stephens is speaking on employment law issues on the Barristers Club of The Bar Association of San Francisco live webinar, "Advising Businesses and Practicing Law During COVID-19." Details: A comprehensive, one-stop shop CLE on the...

Read More
Publication

Coronavirus (COVID-19) Insights and Resources

The spread of the coronavirus (COVID-19) is causing disruption throughout the US that we have not seen in generations. Governmental entities, academia, and the private sector are working diligently to contain COVID-19 while it...

Read More
Publication

Trademark Office Deadlines and Coronavirus-Related Delays

With all of the business interruption caused by the COVID-19 pandemic, many worldwide trademark offices have taken steps to recognize the issues caused by the crisis. The offices in which applicants from the U.S...

Read More